{"organizations": [], "uuid": "04ccb3437dc931f43784b887083d58bc73df4868", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-luye-pharma-group-says-fda-to-waiv/brief-luye-pharma-group-says-fda-to-waive-pediatric-clinical-trials-of-schizophrenia-drug-idUSFWN1QB0IS", "country": "US", "domain_rank": 408, "title": "BRIEF-Luye Pharma Group Says FDA To Waive Pediatric Clinical Trials Of Schizophrenia Drug", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-21T16:46:00.000+02:00", "replies_count": 0, "uuid": "04ccb3437dc931f43784b887083d58bc73df4868"}, "author": "", "url": "https://www.reuters.com/article/brief-luye-pharma-group-says-fda-to-waiv/brief-luye-pharma-group-says-fda-to-waive-pediatric-clinical-trials-of-schizophrenia-drug-idUSFWN1QB0IS", "ord_in_thread": 0, "title": "BRIEF-Luye Pharma Group Says FDA To Waive Pediatric Clinical Trials Of Schizophrenia Drug", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda to waive pediatric clin", "sentiment": "negative"}, {"name": "fda to waive pediatric clinical trials of schizophrenia drug february", "sentiment": "negative"}, {"name": "brief-luye pharma group", "sentiment": "negative"}, {"name": "reuters) - luye pharma group ltd", "sentiment": "none"}, {"name": "fda", "sentiment": "none"}, {"name": "schizophrenia drug reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 21, 2018 / 2:46 PM / in 16 minutes BRIEF-Luye Pharma Group Says FDA To Waive Pediatric Clinical Trials Of Schizophrenia Drug Reuters Staff Feb 21 (Reuters) - Luye Pharma Group Ltd: * FDA AGREES TO WAIVE PEDIATRIC CLINICAL TRIALS OF SCHIZOPHRENIA DRUG LY03004 * FDAâ€˜S DECISION WILL SIGNIFICANTLY REDUCE RESEARCH AND DEVELOPMENT COST Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-21T16:46:00.000+02:00", "crawled": "2018-02-21T17:03:36.029+02:00", "highlightTitle": ""}